Depression: What We can Learn from Postmortem Studies

The existence of depression has been recognized for decades, but its precise neurobiological basis remains unknown. Whereas neuroimaging studies unravel the gross morphological localization of dysfunctional brain regions in depression, postmortem studies provide further insights into the cellular and neurochemical substrates of depression. Recent cell-counting studies have established that major depressive disorder and bipolar illness are characterized by alterations in the density and size of neuronal and glial cells in frontolimbic brain regions. It remains to be fully elucidated to what extent these findings represent neurodevelopmental abnormalities or disease progression and whether the cellular changes observed in depression can be reversed by antidepressant and mood-stabilizing medications. Efforts to unravel specific groups of genes that are compromised in depression have recently been undertaken by investigators in the postmortem research field. Future studies will determine whether these genes may be novel targets of therapeutic medications.

[1]  Paul J. Harrison,et al.  Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs , 2000, Molecular Psychiatry.

[2]  R. Duman,et al.  Neuronal plasticity and survival in mood disorders , 2000, Biological Psychiatry.

[3]  G. Rajkowska,et al.  Morphological Brain Changes in Depression , 2002, CNS drugs.

[4]  P. Goldman-Rakic,et al.  Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. , 1995, Archives of general psychiatry.

[5]  K Amunts,et al.  The importance of a human 3D database and atlas for studies of prefrontal and thalamic functions. , 2000, Progress in brain research.

[6]  G. MacQueen,et al.  Increased hippocampal bdnf immunoreactivity in subjects treated with antidepressant medication , 2001, Biological Psychiatry.

[7]  C. Stockmeier,et al.  Monoamine Receptors in Postmortem Brain: Do Postmortem Brain Studies Cloud or Clarify our Understanding of the Affective Disorders? , 2002 .

[8]  Christopher A. Ross,et al.  Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease , 1991, Neuroscience Letters.

[9]  G. Rosoklija,et al.  Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. , 2000, Archives of general psychiatry.

[10]  B. Roth,et al.  Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression∗ ∗ See accompanying Editorial, in this issue. , 1999, Biological Psychiatry.

[11]  P. Goldman-Rakic,et al.  Segregation of serotonin 5‐HT2A and 5‐HT3 receptors in inhibitory circuits of the primate cerebral cortex , 2000, The Journal of comparative neurology.

[12]  G. MacQueen,et al.  G Protein‐Coupled Cyclic AMP Signaling in Postmortem Brain of Subjects with Mood Disorders , 1999, Journal of neurochemistry.

[13]  P A Sargent,et al.  Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. , 2000, Archives of general psychiatry.

[14]  V. Arango,et al.  A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. , 2000, Archives of general psychiatry.

[15]  Yvette I. Sheline,et al.  Depression Duration But Not Age Predicts Hippocampal Volume Loss in Medically Healthy Women with Recurrent Major Depression , 1999, The Journal of Neuroscience.

[16]  G. Rajkowska,et al.  Glia pathology in the prefrontal cortex in alcohol dependence with and without depressive symptoms , 2002, Biological Psychiatry.

[17]  C. Beasley,et al.  The density and spatial distribution of gabaergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia , 2002, Biological Psychiatry.

[18]  Jon Sinclair,et al.  Astroglia and glutamate in physiology and pathology: aspects on glutamate transport, glutamate-induced cell swelling and gap-junction communication , 2000, Neurochemistry International.

[19]  J. Warsh,et al.  cAMP Signal Transduction Abnormalities in the Pathophysiology of Mood Disorders: Contributions from Postmortem Brain Studies , 2002 .

[20]  N. Uranova,et al.  Decreased numerical density of oligodendroglial cells in postmortem prefrontal cortex in schizophrenia, bipolar affective disorder and major depression , 2000, Schizophrenia Research.

[21]  C. Pariante,et al.  Glial Pathology in Major Psychiatric Disorders , 2002 .

[22]  L. Selemon,et al.  Regionally diverse cortical pathology in schizophrenia: clues to the etiology of the disease. , 2001, Schizophrenia bulletin.

[23]  J. Kleinman,et al.  Neuropathology of bipolar disorder , 2000, Biological Psychiatry.

[24]  V. Klimek,et al.  73 NEUROCIRCUITRY OF MOOD DISORDERS , 2002 .

[25]  M. Raichle,et al.  Subgenual prefrontal cortex abnormalities in mood disorders , 1997, Nature.

[26]  B. Grant,et al.  Major depression in 6050 former drinkers: association with past alcohol dependence. , 2002, Archives of general psychiatry.

[27]  P. Goldman-Rakic,et al.  Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46 and relationship to the Talairach Coordinate System. , 1995, Cerebral cortex.

[28]  L. Friedman,et al.  Neurokinin-1 receptors are decreased in major depressive disorder , 2002, Neuroreport.

[29]  G. Rajkowska Cell pathology in bipolar disorder. , 2002, Bipolar disorders.

[30]  W. Honer Indications of Abnormal Connectivity in Neuropsychiatric Disorders in Postmortem Studies , 2002 .

[31]  P. Goldman-Rakic,et al.  Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. , 1998, Archives of general psychiatry.

[32]  R. Kerwin,et al.  Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. , 2001, Archives of general psychiatry.

[33]  G. Rajkowska,et al.  Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder , 2000, Biological Psychiatry.

[34]  W. Drevets,et al.  The cellular neurobiology of depression , 2001, Nature Medicine.

[35]  Yogesh K. Dwivedi,et al.  Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. , 2000, Archives of general psychiatry.

[36]  G. Rajkowska,et al.  Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells , 2000, Biological Psychiatry.

[37]  J. Price,et al.  Low glial numbers in the amygdala in major depressive disorder , 2002, Biological Psychiatry.

[38]  G. Nowak,et al.  Alterations in the N-methyl-d-asparatate (NMDA) receptor complex in the frontal cortex of suicide victims , 1995, Brain Research.

[39]  J. Janosky,et al.  Localized decrease in serotonin transporter-immunoreactive axons in the prefrontal cortex of depressed subjects committing suicide , 2002, Neuroscience.

[40]  C. Beasley,et al.  Selective deficits of frontal cortical gabaergic neuronal subtypes defined by calcium binding proteins in psychotic illness , 2000, Schizophrenia Research.

[41]  Kimberly Hoagwood,et al.  Development and natural history of mood disorders , 2002, Biological Psychiatry.

[42]  D. Lewis The catecholaminergic innervation of primate prefrontal cortex. , 1992, Journal of neural transmission. Supplementum.

[43]  H. Supèr,et al.  The functions of the preplate in development and evolution of the neocortex and hippocampus , 1998, Brain Research Reviews.

[44]  N. Uranova,et al.  Electron microscopy of oligodendroglia in severe mental illness , 2001, Brain Research Bulletin.

[45]  J. Krystal,et al.  Impairment of GABAergic transmission in depression: new insights from neuroimaging studies. , 2000, Critical reviews in neurobiology.

[46]  R. Sapolsky,et al.  The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death , 2000, Biological Psychiatry.

[47]  R. Rodnight,et al.  Lithium treatment causes gliosis and modifies the morphology of hippocampal astrocytes in rats , 1998, Neuroreport.

[48]  David A Lewis,et al.  Neural and behavioral substrates of mood and mood regulation , 2002, Biological Psychiatry.

[49]  F. Holsboer,et al.  Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. , 2001, The American journal of pathology.

[50]  R. Yolken,et al.  Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder , 2000, Molecular Psychiatry.

[51]  G F Mason,et al.  Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments , 2002, Molecular Psychiatry.

[52]  Sabine Landau,et al.  Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. , 2002, Cerebral cortex.

[53]  L. Selemon,et al.  Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder , 2001, Biological Psychiatry.

[54]  J. Price,et al.  Glial reduction in the subgenual prefrontal cortex in mood disorders. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Eric Vermetten,et al.  Reduced volume of orbitofrontal cortex in major depression , 2002, Biological Psychiatry.

[56]  J. John Mann,et al.  Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims , 1995, Brain Research.